Internal Medicine
Podcast: Treatment of acute heart failure
8 Sep, 2020 | 01:00h | UTC#230 Kittleson Rules Acute Heart Failure – The Curbsiders Internal Medicine Podcast
Coalition Covid-19 Brazil – Randomized trial: Azithromycin not beneficial for patients admitted to the hospital with severe Covid-19
6 Sep, 2020 | 22:06h | UTCInvited Commentary: Azithromycin for severe COVID-19
Commentaries on Twitter
This network of Brazilian researchers has done an AMAZING job of getting organized & answering important ?s. In this Lancet article they show in a randomized trial that #azithromycin does not improve #Covid19 outcomes. @RenatoDLopes1 https://t.co/zL7GSaVqm8
— C. Michael Gibson MD (@CMichaelGibson) September 5, 2020
New trial @TheLancet does not support the routine use of azithromycin in combination with #Hydroxychloroquine in patients with severe #COVIDー19:https://t.co/vaj1XX3dSo
— Madhu Pai, MD, PhD (@paimadhu) September 6, 2020
Podcast: Hyponatremia deconstructed
8 Sep, 2020 | 01:01h | UTCREBOOT #48 Hyponatremia Deconstructed – The Curbsiders Internal Medicine Podcast
We have heard your message about long covid and we will act, says WHO
6 Sep, 2020 | 21:59h | UTCWe have heard your message about long covid and we will act, says WHO – The BMJ Opinion
Commentary on Twitter
I joined an inspiring meeting with #COVID19 patient groups. My colleague @mvankerkhove contacted these great advocates who strive to increase research, rehabilitation and recognition for people suffering long-term effects of the virus. @WHO is committed to supporting their goals. https://t.co/wJpYupcLjQ
— Tedros Adhanom Ghebreyesus (@DrTedros) August 22, 2020
A living WHO guideline on drugs for Covid-19
6 Sep, 2020 | 22:04h | UTCA living WHO guideline on drugs for covid-19 – The BMJ
Commentary on Twitter
NEW #RapidRec makes a strong recommendation for systemic corticosteroids in patients with severe and critical #COVID19 and a weak or conditional recommendation against systemic corticosteroids in patients with non-severe covid-19 https://t.co/p7loBk95Vm
— The BMJ (@bmj_latest) September 5, 2020
Video: Long covid: diagnosis, management, prognosis
6 Sep, 2020 | 21:58h | UTCLong covid: diagnosis, management, prognosis – The BMJ
Commentary on Twitter
#LongCovid #BMJcovid – Many patients who have relatively mild symptoms from covid-19, continue to experience these long after the usual 12 day duration.
Our panel discusses "Long covid" – it's diagnosis, management and prognosis https://t.co/hsP1TRNCt3 via @YouTube
— The BMJ (@bmj_latest) September 5, 2020
Coronavirus reinfections: Three questions scientists are asking
6 Sep, 2020 | 21:56h | UTCCoronavirus reinfections: three questions scientists are asking – Nature
Does the COVID-19 cytokine storm exist?
6 Sep, 2020 | 21:55h | UTCDoes the COVID-19 cytokine storm exist? – Radboud University Medical Center
Original Study: Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions – JAMA
Commentary on Twitter
Study suggests #COVID19 may not be characterized by cytokine storm. Whether anticytokine therapies will benefit patients with COVID-19 remains to be determined https://t.co/alyFUwCYRC
— JAMA (@JAMA_current) September 4, 2020
Infographic. Clinical recommendations for return to play during the COVID-19 pandemic
6 Sep, 2020 | 21:54h | UTC
Commentary on Twitter
Took a while for this to be out but excited 2 see our paper made it to infographic @BJSM_BMJ Clinical recommendations for return to play during the COVID-19 pandemichttps://t.co/rS3bCeP4Qg
Huge Collective Viewpoint by @SportswiseUK @aaashafik @GrahamHolloway4 @merseysportsmed pic.twitter.com/icYjY4D1e1— Dr Dora Papadopoulou (@Dora_Sportmed) September 4, 2020
COVID-19 in healthcare workers: A living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes
6 Sep, 2020 | 21:49h | UTC
Commentary on Twitter
The figure summarizes the main findings of our meta-analysis published yesterday at the American Journal of Epidemiology.
Health care workers suffer a significant burden
from #COVID19 https://t.co/ymI56TRbm1
@SergioA18489499 @ISPMBern @OscarH_Franco @diromiza pic.twitter.com/NCaqD0xOET— Taulant Muka (@muka_taulant) September 2, 2020
A direct comparison of enhanced saliva to nasopharyngeal swab for the detection of SARS-CoV-2 in symptomatic patients
6 Sep, 2020 | 21:51h | UTC
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline
6 Sep, 2020 | 21:43h | UTC
Invasive Fungal Disease complicating COVID-19: when it rains it pours
6 Sep, 2020 | 21:38h | UTCInvasive Fungal Disease complicating COVID-19: when it rains it pours – Clinical Infectious Diseases
Related study: A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU – Clinical Infectious Diseases
Commentary on Twitter
Read the fantastic editorial commentary by @martinhoenigl
Invasive Fungal Disease complicating COVID-19: when it rains it pours. #COVID19 @eurconfmedmycol #CID https://t.co/3M7NYI3zwk https://t.co/2YKpQ3x9TP— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 5, 2020
#ESCCongress – [Not Published Yet] Trial clarifies which patients with acute pulmonary embolism can be managed at home
6 Sep, 2020 | 21:36h | UTCNews Release: Trial clarifies which patients with acute pulmonary embolism can be managed at home – European Society of Cardiology
HESTIA Calculator: Hestia Criteria for Outpatient Pulmonary Embolism Treatment – MdCalc
sPESI Calculator: Simplified PESI (Pulmonary Embolism Severity Index) – MeCalc
Systematic review: Association between D-Dimer levels and mortality in patients with COVID-19
6 Sep, 2020 | 21:37h | UTC
[Abstract Only] Randomized trial: Aspirin increases major GI bleeding risk by 60% in older individuals
6 Sep, 2020 | 21:30h | UTCSource: EvidenceAlerts
Commentary on Twitter
Aspirin increases GI bleeding risk by 60% in an aspirin RCT
137 total GI bleeds in 90000 person years @Gut_BMJ https://t.co/Hb8h6kZrpo
— Elliot Tapper (@ebtapper) August 8, 2020
Randomized trial: Preoperative intravenous iron to treat anemia 10–42 days before major abdominal surgery does not reduce the need for blood transfusion
6 Sep, 2020 | 21:28h | UTC
Commentary on Twitter
Startling finding. In a blinded RCT, preop iron transfusion did not ⬇️complications, or a ⬇️transfusions after major abdominal surgery. While Hb ⬆️, no real tangible benefit occurred.
Periop medicine & optimization is complicated! #colorectalsurgery https://t.co/q0HhR3JCy3— Ahmer Karimuddin (@ahmerkarimuddin) September 5, 2020
Image: SARS-CoV-2 infection of airway cells
4 Sep, 2020 | 02:15h | UTCImages in Clinical Medicine: SARS-CoV-2 Infection of Airway Cells – New England Journal of Medicine
Editorial: Are we underestimating seroprevalence of SARS-CoV-2?
4 Sep, 2020 | 02:17h | UTCAre we underestimating seroprevalence of SARS-CoV-2? – The BMJ
Commentary: Are antibody tests underestimating the spread of COVID-19? – St. George’s University of London
Review: Coagulopathy of Covid-19
4 Sep, 2020 | 02:14h | UTCCoagulopathy of Coronavirus Disease 2019 – Critical Care Medicine
Commentary on Twitter
What you need to know about #Covid19 #coagulopathy is all in one place – @CCM. This will help target your anticoagulation plans for COVID care. @SCCM https://t.co/gKUbc995ra
— Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FAAN, FCCM (@SCCMPresident) September 1, 2020
Case report: Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection
4 Sep, 2020 | 02:10h | UTCCommentary: Can COVID-19 cause diabetes? – MedicalXpress
Commentary on Twitter
https://twitter.com/nresearchnews/status/1301179637704331265
Coalition Covid-19 Brazil – Randomized trial: Dexamethasone improves outcomes in patients with Acute Respiratory Distress Syndrome and COVID-19
3 Sep, 2020 | 11:24h | UTCEditorial: Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic
Related studies: Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial – JAMA AND Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial – JAMA
Commentary: Inexpensive Steroids Can Save Lives Of Seriously Ill COVID-19 Patients – NPR
Commentary on Twitter
In this RCT, IV #dexamethasone increased the number of ventilator-free days by day 28 vs standard care alone among patients with #COVID19 and moderate or severe ARDS https://t.co/RA9G6LVRlz @ICURevisited @FlaviaSepsis @israelmaia16
— JAMA (@JAMA_current) September 2, 2020
Malignant pleural effusions: New evidence on management
4 Sep, 2020 | 02:03h | UTCMalignant pleural effusions (MPE): new evidence on management – Evidently Cochrane
Original Review: Interventions for the management of malignant pleural effusions: a network meta‐analysis – Cochrane Library
Video: Corticosteroids for COVID-19 – New Evidence of Benefit
3 Sep, 2020 | 11:21h | UTCCorticosteroids for COVID-19 – New Evidence of Benefit – JAMA
Meta-analysis: Corticosteroids for critically ill patients with COVID-19
3 Sep, 2020 | 11:23h | UTCEditorial: Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic
Commentaries: Analysis of seven trials finds that corticosteroids reduce risk of death by 20 per cent in critically ill COVID-19 patients – University of Bristol AND Multiple studies confirm steroids can fight severe COVID-19 – MedicalXpress
Commentary on Twitter
1/8 Corticosteroids and COVID19
*Three* RCTs and a new @WHO meta-analysis add to #RECOVERY trial data that corticosteroids reduce mortality in critically ill #COVID19 patientshttps://t.co/H8c46Y5DTm— JAMA (@JAMA_current) September 2, 2020